Eden Research (LON:EDEN) Stock Price Down 3.3% – Time to Sell?

Eden Research plc (LON:EDEN) dropped 3.3% during trading on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares changed hands during trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The firm has a market capitalization of £18.56 million, a PE ratio of -12.19 and a beta of 0.92. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The business’s fifty day moving average price is GBX 3.87 and its 200 day moving average price is GBX 3.95.

Insider Transactions at Eden Research

In related news, insider Alexander John Abrey bought 540,540 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek bought 256,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 6th. The stock was bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.